• Price (USD)4.21
  • Today's Change-0.38 / -8.28%
  • Shares traded7.28m
  • 1 Year change-55.64%
  • Beta1.6100
Data delayed at least 15 minutes, as of Jan 25 2022 21:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Amyris, Inc. is a synthetic biotechnology company. The Company applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The Company's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The Company is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance.

  • Revenue in USD (TTM)356.79m
  • Net income in USD-417.13m
  • Incorporated2010
  • Employees595.00
  • Location
    Amyris Inc5885 Hollis St Ste 100EMERYVILLE 94608-2405United StatesUSA
  • Phone+1 (510) 450-0761
  • Fax+1 (510) 225-2645
  • Websitehttps://www.amyris.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AMRS:NSQ since
MG Empower LtdDeal completed11 Aug 202111 Aug 2021Deal completed-71.32%--
OLIKA IncDeal completed15 Jun 202115 Jun 2021Deal completed-73.12%--
Ecofabulous CosmeticsDeal completed15 Apr 202115 Apr 2021Deal completed-73.77%--
Beauty Labs International LtdDeal completed14 Apr 202114 Apr 2021Deal completed-72.59%--
Upland1 LLCAnnounced01 Mar 202101 Mar 2021Announced-69.49%--
Data delayed at least 15 minutes, as of Jan 25 2022 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Gevo Inc1.19m-60.74m670.18m31.00--1.20--564.13-0.3689-0.36890.00682.770.00294.182.6938,322.58-14.66-29.99-15.51-35.56-761.11-43.23-5,113.13-134.8913.07-4.930.1374---77.39-28.74-40.22--32.17--
Origin Materials Inc0.0011.05m728.87m2.00139.202.3619.59---0.0999-0.09990.002.190.00----0.001.78--1.82-------------0.81130.0171--------------
Valhi, Inc.2.13bn95.40m746.52m2.24k7.890.99463.680.35053.353.5074.7426.540.74943.346.18950,044.604.966.786.428.8523.7226.306.6210.263.175.590.39416.79-2.524.453.46--3.71-12.94
Hawkins, Inc.670.42m47.76m800.59m742.0016.812.7911.,525.6010.604.5712.405.3620.3218.857.123.481.3945.650.227648.7310.497.5944.4617.70-2.9719.30
LSB Industries, Inc.454.91m-293.58m908.67m573.00--2.17--2.00-7.54-7.5411.874.750.424321.278.64793,916.30-1.89-5.74-2.12-6.4012.54-0.3149-4.45-17.871.070.42070.5268---3.77-4.30-3.09---41.35--
Westlake Chemical Partners LP1.13bn68.06m932.13m2.17k13.691.782.090.82491.931.9332.107.980.824182.114.36--24.6523.6049.6251.0733.5935.0729.9231.095.2238.870.306497.28-11.47-0.81858.5010.68-30.699.80
CVR Partners LP433.96m-217.00k1.06bn287.003,366.133.4114.872.450.02960.029640.3129.210.41035.2716.851,512,056.00-0.0205-4.94-0.0225-5.2836.3430.38-0.05-15.781.191.070.6671---13.423.89-180.77--1.79-21.09
Amyris Inc356.79m-417.13m1.30bn595.00------3.64-1.49-1.491.25-0.28970.95372.198.67599,638.60-111.08-145.09-556.43-10,085.0766.4445.48-116.48-179.820.4478-1.341.21--13.4938.35-41.41--30.58--
Ecovyst Inc446.93m-206.19m1.32bn2.27k--1.86--2.95-1.51-3.443.285.160.14352.213.22196,536.90-6.74-1.12-7.18-1.2026.3324.80-46.98-3.591.474.130.5554---7.7123.28-370.61--18.83--
Kronos Worldwide, Inc.1.86bn91.50m1.68bn2.24k18.412.0511.670.90660.79210.792116.097.110.94063.115.82828,858.204.639.765.2911.2822.3026.264.9210.223.066.740.359746.31-5.333.97-26.64--5.923.71
Green Plains Inc2.50bn-113.75m1.72bn839.00--1.77--0.6857-2.84-2.6255.3418.131.3710.8034.592,984,044.00-5.03-2.08-6.92-3.237.756.69-3.67-1.622.16-0.33930.389---20.42-8.2910.33--11.79--
Ferro Corporation1.12bn52.65m1.79bn5.62k34.013.4819.031.600.63511.8313.486.200.69092.847.33199,442.003.342.454.213.1031.4731.184.843.901.224.680.4092---5.47-2.26-14.14-22.09-5.90--
Data as of Jan 25 2022. Currency figures normalised to Amyris Inc's reporting currency: US Dollar USD

Institutional shareholders

23.10%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202117.42m5.65%
BlackRock Fund Advisorsas of 30 Sep 202112.21m3.96%
Farallon Capital Management LLCas of 30 Sep 202111.72m3.80%
BlackRock Advisors LLCas of 30 Sep 202110.62m3.45%
Pinnacle Associates Ltd.as of 30 Sep 20214.64m1.51%
SSgA Funds Management, Inc.as of 30 Sep 20213.42m1.11%
Geode Capital Management LLCas of 30 Sep 20213.33m1.08%
Lord, Abbett & Co. LLCas of 30 Sep 20213.26m1.06%
Susquehanna Financial Group LLLPas of 30 Sep 20212.63m0.85%
Tanaka Capital Management, Inc.as of 30 Sep 20211.94m0.63%
More ▼
Data from 30 Sep 2021 - 30 Sep 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.